PEG 400 Ion Suppression in Busulfan Detection by High-Performance Liquid Chromatography—Tandem Mass Spectrometry
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PEG 400 Ion Suppression in Busulfan Detection by High-Performance Liquid Chromatography—Tandem Mass Spectrometry
Authors
Keywords
-
Journal
THERAPEUTIC DRUG MONITORING
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-09-09
DOI
10.1097/ftd.0000000000001130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Simultaneously measure the concentrations of busulfan and phenytoin in human plasma using an HPLC-MS/MS method: Application to the TDM for children underwent hematological stem cell transplantation
- (2022) Ning Sun et al. ACTA CHROMATOGRAPHICA
- A rapid HPLC‐MS/MS method for determining busulfan in hemolysis samples from children with hematopoietic stem cell transplantation
- (2020) Yuan Jinjie et al. BIOMEDICAL CHROMATOGRAPHY
- UPLC-Tandem Mass Spectrometry for Quantification of Busulfan in Human Plasma: Application to Therapeutic Drug Monitoring
- (2020) Kamal M. Matar et al. Scientific Reports
- Comparison of Two Analytical Methods for Busulfan Therapeutic Drug Monitoring
- (2020) Simona De Gregori et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Stability-Indicating Method Development and Validation for Busulfan Drug Substance by Gas Chromatography-Flame Ionization Detector
- (2020) Ashraf Khan et al. JOURNAL OF CHROMATOGRAPHIC SCIENCE
- Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry
- (2019) Ryan C. Schofield et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- A rapid and simple LC–MS/MS method for personalized busulfan dosing in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT)
- (2018) Yi Xiao et al. CLINICA CHIMICA ACTA
- Simultaneous quantification of busulfan, clofarabine and F-ARA-A using isotope labelled standards and standard addition in plasma by LC–MS/MS for exposure monitoring in hematopoietic cell transplantation conditioning
- (2017) Arjen. M. Punt et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- LC–MS/MS method development for quantification of busulfan in human plasma and its application in pharmacokinetic study
- (2016) Taraka Ramarao Nadella et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Development and Validation of a Liquid Chromatography–Tandem Mass Spectrometry Assay to Quantify Plasma Busulfan
- (2014) Deborah French et al. THERAPEUTIC DRUG MONITORING
- Quantification of Human Plasma-Busulfan Concentration by Liquid Chromatography-Tandem Mass Spectrometry
- (2014) Soo Young Moon et al. Annals of Laboratory Medicine
- Method agreement analysis: A review of correct methodology
- (2010) P.F. Watson et al. THERIOGENOLOGY
- Busulfan in hematopoietic stem cell transplant setting
- (2009) Jeannine S McCune et al. Expert Opinion on Drug Metabolism & Toxicology
- Once-Daily Intravenous Busulfan with Therapeutic Drug Monitoring Compared to Conventional Oral Busulfan Improves Survival and Engraftment in Children Undergoing Allogeneic Stem Cell Transplantation
- (2007) Imke H. Bartelink et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started